Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height

Aceragen

Aceragen Inc reported $21.42M in Current Liabilities for its fiscal quarter ending in December of 2022.


Current Liabilities Change
Abbott ABT:US USD 14.53B 959M
Aceragen Inc IDRA:US USD 21.42M 2.19M
Agenus AGEN:US USD 190.9M 1.95M
Alnylam Pharmaceuticals ALNY:US USD 673.39M 94.52M
Amgen AMGN:US USD 14.22B 1.47B
Biogen BIIB:US USD 3.01B 257.9M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Dynavax Technologies DVAX:US USD 91.52M 58.56M
Eli Lilly LLY:US USD 16.01B 1.13B
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Roche Holding ROG:VX CHF 27.24B 170M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Seattle Genetics SGEN:US USD 713.23M 105.18M
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M